DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹633 Cr | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr | ₹-197 Cr |
What is the latest Total Non-Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹633 Cr |
| Mar2024 | ₹-37 Cr |
| Mar2023 | ₹-278 Cr |
| Mar2022 | ₹-508 Cr |
| Mar2021 | ₹-197 Cr |
How is Total Non-Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹633 Cr | Positive | |
| Mar2024 | ₹-37 Cr | Negative | |
| Mar2023 | ₹-278 Cr | Negative | |
| Mar2022 | ₹-508 Cr | Negative | |
| Mar2021 | ₹-197 Cr | - | |
Compare Total Non-Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,807.9 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| MANKIND PHARMA | ₹84,111.1 Cr | -1.1% | -3% | -16.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1% |
10.8% |
4.7% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses